Apoptotic response of hL-60 human leukemia cells to the antitumor drug TAS-103

Cancer Research

Volumn 60, Issue 15, 2000, Pages 4077-4084

  Kluza, J ^a   Lansiaux, A ^a   Wattez, N ^a   Mahieu, C ^a   Osheroff, N ^a   Bailly, C ^a  

^a INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

6 [2 (DIMETHYLAMINO)ETHYLAMINO] 3 HYDROXY 7H INDENO[2,1 C]QUINOLIN 7 ONE; ANTINEOPLASTIC AGENT; CASPASE 3; CASPASE 8; DNA FRAGMENT; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CELL PH; CONCENTRATION RESPONSE; CYTOTOXICITY; DNA CLEAVAGE; DRUG RESPONSE; DRUG STRUCTURE; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LEUKEMIA; LEUKEMIA CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROCESSING;

AMINOQUINOLINES; ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CASPASES; CELL CYCLE; DNA FRAGMENTATION; ENZYME ACTIVATION; ENZYME ACTIVATORS; FLOW CYTOMETRY; HL-60 CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; INDENES; INTERCALATING AGENTS; INTRACELLULAR MEMBRANES; MEMBRANE POTENTIALS; MITOCHONDRIA; PHOSPHATIDYLSERINES; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION;

EID: 0033881381     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (46)

1. Antitumor activity of TAS-103, a novel topoisomerase I and II inhibitor
2. Antitumor activity of TAS-103, a novel topoisomerase I and II inhibitor, against orthotopically implanted human cancers
3. Mechanism of action of the dual topoisomerase-I and -II inhibitor TAS-103 and activity against (multi)drug resistant cells
4. Combination effects of TAS-103, a novel dual topoisomerase I and II inhibitor, with other anticancer agents on human small cell lung cancer cells
5. DNA topoisomerases as targets for the anticancer drug TAS-103: DNA interactions and topoisomerase catalytic inhibition
6. DNA topoisomerases as targets for the anticancer drug TAS-103: Primary cellular target and DNA cleavage enhancement
7. Cytotoxic mechanism of TAS-103 is related to topoisomerase II-mediated DNA cleavage
8. Apoptosis and its modulation in human promyelocytic HL60 cells treated with DNA topoisomerase I and II inhibitors
9. Differential induction of apoptosis in undifferentiated and differentiated HL-60 cells by DNA topoisomerases I and II inhibitors
10. Camptothecin-induced apoptosis in p53-null human leukemia HL60 cells and their isolated nuclei: Effects of the protease inhibitors Z-VAD-fmk and dichloroisocoumarin suggest an involvement of both caspases and serine proteases
11. Use of an aqueous soluble tetrazolium/formazan assay for cell growth assays
12. The mitochondrial death/life regulator in apoptosis and necrosis
13. The permeability transition pore as a mitochondrial calcium release channel: A critical appraisal
14. 2,4-Dinitrophenol-uncoupling effect on Δψ in living hepatocytes depends on reducing-equivalent supply
15. Flow cytometric analysis of altered mononuclear cell transmembrane potential induced by cyclosporin
16. Flow cytometric analysis of mitochondrial activity in situ: Application to acetylceramide-induced mitochondrial swelling and apoptosis
17. Swelling and contraction of the mitochondrial matrix. I. A structural interpretation of the relationship between light scattering and matrix volume
18. The regulation of the matrix volume of mammalian mitochondria in vivo and in vitro and its role in the control of mitochondrial metabolism
19. Intracellular heterogeneity in mitochondrial membrane potentials revealed by a J-aggregate forming lipophilic cation
20. Cell acidification in apoptosis: Granulocyte colony-stimulating factor delays programmed cell death in neutrophils by up-regulating the vacuolar H(+)-ATPase
21. Etoposide-induced apoptosis in human HL-60 cells is associated with intracellular acidification
22. Relation between intracellular acidification and camptothecin-induced apoptosis in leukemia cells
23. Proteolytic activities that mediate apoptosis
24. Cell death induced by topoisomerase-targeted drugs: More questions than answers
25. Caspases and caspase inhibitors
26. Yama/CPP32 β, a mammalian homolog of CED-3, is a CrmA-inhibitable protease that cleaves the death substrate poly(ADP-ribose) polymerase
27. Poly(ADP-ribosylation) of a DNA topoisomerase
28. Poly(ADP-ribose) polymerase. A molecular nick-sensor
29. FLICE induced apoptosis in a cell-free system. Cleavage of caspase zymogens
30. Pro-caspase-3 is a major physiologic target of caspase-8
31. Investigation of the subcellular distribution of the bcl-2 oncoprotein: Residence in the nuclear envelope, endoplasmic reticulum, and outer mitochondrial membranes
32. Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade
33. Activation of multiple interleukin-1β converting enzyme homologues in cytosol and nuclei of HL-60 cells during etoposide-induced apoptosis
34. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase
35. Annexin V-affinity assay: A review on an apoptosis detection system based on phosphatidylserine exposure
36. Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity
37. Phosphatidylserine externalization is a downstream event of interleukin-I β-converting enzyme family protease activation during apoptosis
38. A biochemical hallmark of apoptosis: Internucleosomal degradation of the genome
39. Simultaneous determination of cell surface antigens and apoptosis
40. Identification of dying cells - In situ staining
41. Caspase-mediated activation of PAK2 during apoptosis: Proteolytic kinase activation as a general mechanism of apoptotic signal transduction?
42. Mitochondrial release of caspase-2 and -9 during the apoptotic process
43. The central executioner of apoptosis. Multiple links between protease activation and mitochondria in Fas/Apo-1/CD95- and ceramide-induced apoptosis
44. Effect of intracellular acidity and ionomycin on apoptosis in HL-60 cells
45. Role of intracellular pH in proliferation, transformation, and apoptosis
46. Differential effect of metabolic inhibitors on cellular and mitochondrial uptake of organic cations in rat liver